NATIONAL HEALTHCARE CORP·4

Jan 16, 4:01 PM ET

ABERNATHY JAMES PAUL 4

4 · NATIONAL HEALTHCARE CORP · Filed Jan 16, 2026

Insider Transaction Report

Form 4
Period: 2026-01-15
Transactions
  • Exercise/Conversion

    Shares of Common Stock

    [F1]
    2026-01-15$69.82/sh+7,500$523,65043,894 total
  • Tax Payment

    Shares of Common Stock

    [F2][F3]
    2026-01-15$139.01/sh3,732$518,78540,162 total
  • Exercise/Conversion

    Option to Purchase Common Stock [2022 Grant]

    [F1]
    2026-01-157,5000 total
    Exercise: $69.19From: 2023-05-05Exp: 2027-05-04Common Stock (7,500 underlying)
Holdings
  • Option to Purchase Common Stock [2023 Grant]

    Exercise: $55.75From: 2024-05-04Exp: 2028-05-03Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2024 Grant]

    Exercise: $96.03From: 2025-05-09Exp: 2029-05-08Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2025 Grant]

    Exercise: $94.66From: 2026-05-08Exp: 2030-05-07Common Stock (7,500 underlying)
    7,500
Footnotes (3)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F2]Shares were withheld by the Company to pay the exercise price.
  • [F3]Total amount of shares beneficially owned following transactions reported on this form.
Signature
/s/ James Paul Abernathy|2026-01-16

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4